Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

789
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
789
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

602
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
602
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

621
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
621
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

425
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
425
Cancer Survival Analysis01:21

Cancer Survival Analysis

765
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
765
Sign Test for Matched Pairs01:17

Sign Test for Matched Pairs

411
The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
411

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extending the Median Odds Ratio (MOR), the Interval Odds Ratio (IOR), and the Proportion of Opposed Odds Ratios (POOR) for Use With 3-Level Multilevel Logistic Regression Models.

Statistics in medicine·2026
Same author

Using Propensity Score Weighting With Clustered Data When the Treatment Is Applied at the Level of the Cluster and Outcomes Are Assessed at the Level of the Individual: The Observational Analog of Cluster Randomization Trials.

Statistics in medicine·2026
Same author

The Impact of Two Data-Generating Processes for Competing Risk Data on the Discrimination and Calibration of Two Types of Competing Risk Regression Models.

Statistics in medicine·2026
Same author

A nonparametric dependent competing risk method for net survival analysis.

The international journal of biostatistics·2026
Same author

Patterns and Outcomes of Completeness of Revascularization in Patients With Diabetes and Non-ST-Segment-Elevation Myocardial Infarction in Ontario, Canada.

Circulation. Population health and outcomes·2026
Same author

Prediction of transition probabilities in multi-state models with nested case-control data.

Biometrics·2025

Related Experiment Video

Updated: Feb 3, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K

Propensity-score matching with competing risks in survival analysis.

Peter C Austin1,2,3, Jason P Fine4,5

  • 1ICES, Toronto, Ontario, Canada.

Statistics in Medicine
|October 23, 2018
PubMed
Summary
This summary is machine-generated.

Propensity-score matching with competing risks data can estimate treatment effects using cause-specific hazards for relative effects and cumulative incidence functions for absolute effects. A clustered subdistribution hazard model is recommended for analysis.

Keywords:
Monte Carlo simulationscompeting riskcumulative incidence functionmatchingpropensity scorepropensity score matchingsurvival analysis

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.6K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Related Experiment Videos

Last Updated: Feb 3, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.6K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Medical Research

Background:

  • Propensity-score matching (PSM) is used to control confounding in observational studies.
  • Competing risks are common in time-to-event medical research.
  • Guidance on PSM with competing risks is limited.

Purpose of the Study:

  • To describe methods for estimating relative and absolute treatment effects using PSM with competing risks data.
  • To evaluate statistical methods for analyzing competing risks data after PSM.
  • To recommend appropriate statistical models for PSM with competing risks.

Main Methods:

  • Utilized propensity-score matching on observational data.
  • Employed cause-specific hazard models for relative treatment effects.
  • Compared cumulative incidence functions (CIFs) for absolute treatment effects.
  • Conducted Monte Carlo simulations to assess statistical methods.
  • Examined marginal subdistribution hazard models.

Main Results:

  • Relative treatment effects can be estimated using cause-specific hazard models in matched samples.
  • Absolute treatment effects can be estimated by comparing CIFs between matched groups.
  • A marginal subdistribution hazard model accounting for within-pair clustering is recommended for testing CIF equality and estimating subdistribution hazard ratios.

Conclusions:

  • PSM can be effectively applied to competing risks data for treatment effect estimation.
  • Marginal subdistribution hazard models are suitable for analyzing such data.
  • The methods were illustrated using acute myocardial infarction patient data on statin use.